Literature DB >> 12438436

Misfolded, protease-resistant proteins in animal models and human neurodegenerative disease.

Dennis W Dickson1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12438436      PMCID: PMC151824          DOI: 10.1172/JCI17164

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  23 in total

1.  Regional mapping of prion proteins in brain.

Authors:  A Taraboulos; K Jendroska; D Serban; S L Yang; S J DeArmond; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

Review 2.  Amyloidosis.

Authors:  J D Sipe
Journal:  Annu Rev Biochem       Date:  1992       Impact factor: 23.643

Review 3.  Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop.

Authors:  I G McKeith; D Galasko; K Kosaka; E K Perry; D W Dickson; L A Hansen; D P Salmon; J Lowe; S S Mirra; E J Byrne; G Lennox; N P Quinn; J A Edwardson; P G Ince; C Bergeron; A Burns; B L Miller; S Lovestone; D Collerton; E N Jansen; C Ballard; R A de Vos; G K Wilcock; K A Jellinger; R H Perry
Journal:  Neurology       Date:  1996-11       Impact factor: 9.910

4.  Lewy bodies are ubiquitinated. A light and electron microscopic immunocytochemical study.

Authors:  S Kuzuhara; H Mori; N Izumiyama; M Yoshimura; Y Ihara
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

5.  Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins.

Authors:  K M Pan; M Baldwin; J Nguyen; M Gasset; A Serban; D Groth; I Mehlhorn; Z Huang; R J Fletterick; F E Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

6.  Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease: light and electron microscopic immunocytochemistry of CA2-3 neurites specific to DLBD.

Authors:  D W Dickson; D Ruan; H Crystal; M H Mark; P Davies; Y Kress; S H Yen
Journal:  Neurology       Date:  1991-09       Impact factor: 9.910

7.  Demonstration of alpha-synuclein immunoreactivity in neuronal and glial cytoplasm in normal human brain tissue using proteinase K and formic acid pretreatment.

Authors:  Fumiaki Mori; Kunikazu Tanji; Makoto Yoshimoto; Hitoshi Takahashi; Koichi Wakabayashi
Journal:  Exp Neurol       Date:  2002-07       Impact factor: 5.330

8.  Ischemic stress induces deposition of amyloid beta immunoreactivity in human brain.

Authors:  K Jendroska; W Poewe; S E Daniel; J Pluess; H Iwerssen-Schmidt; J Paulsen; S Barthel; L Schelosky; J Cervós-Navarro; S J DeArmond
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

9.  Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases.

Authors:  John E Duda; Benoit I Giasson; Meghann E Mabon; Virginia M-Y Lee; John Q Trojanowski
Journal:  Ann Neurol       Date:  2002-08       Impact factor: 10.422

10.  Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein.

Authors:  Benoit I Giasson; John E Duda; Shawn M Quinn; Bin Zhang; John Q Trojanowski; Virginia M-Y Lee
Journal:  Neuron       Date:  2002-05-16       Impact factor: 17.173

View more
  5 in total

Review 1.  Paraffin-embedded tissue (PET) blot method: application to Alzheimer disease.

Authors:  Calvin F Moh; Sandra L Siedlak; Massimo Tabaton; George Perry; Rudy J Castellani; Mark A Smith
Journal:  J Neurosci Methods       Date:  2010-05-16       Impact factor: 2.390

2.  Tissue transglutaminase, protein cross-linking and Alzheimer's disease: review and views.

Authors:  Deng-Shun Wang; Dennis W Dickson; James S Malter
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

3.  Chiral Effect at Nano-Bio Interface: A Model of Chiral Gold Nanoparticle on Amylin Fibrillation.

Authors:  Jing Li; Rui Chen; Shasha Zhang; Zhongjie Ma; Zhuoying Luo; Guanbin Gao
Journal:  Nanomaterials (Basel)       Date:  2019-03-11       Impact factor: 5.076

4.  Tau-proximity ligation assay reveals extensive previously undetected pathology prior to neurofibrillary tangles in preclinical Alzheimer's disease.

Authors:  Nora Bengoa-Vergniory; Elisavet Velentza-Almpani; Ana Maria Silva; Connor Scott; Mariana Vargas-Caballero; Magdalena Sastre; Richard Wade-Martins; Javier Alegre-Abarrategui
Journal:  Acta Neuropathol Commun       Date:  2021-01-28       Impact factor: 7.801

Review 5.  Applications of Phyto-Nanotechnology for the Treatment of Neurodegenerative Disorders.

Authors:  Tanima Bhattacharya; Giselle Amanda Borges E Soares; Hitesh Chopra; Md Mominur Rahman; Ziaul Hasan; Shasank S Swain; Simona Cavalu
Journal:  Materials (Basel)       Date:  2022-01-21       Impact factor: 3.623

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.